HomeNewsIndiaIndia suspends coronavirus antibody tests after questions over reliability

India suspends coronavirus antibody tests after questions over reliability

India trails many countries in conducting the standard swab tests to determine the presence of the novel coronavirus because of limited testing equipment and protective gear for medical workers.

April 22, 2020 / 15:17 IST

India has ordered a pause in testing for antibodies to the coronavirus because of concern over the accuracy, health officials said on Wednesday, complicating the fight against the epidemic as its tally of cases nears 20,000.

India trails many countries in conducting the standard swab tests to determine the presence of the novel coronavirus because of limited testing equipment and protective gear for medical workers.

Early this month, health authorities approved blood tests for coronavirus antibodies as a faster way to bolster the screening effort and they ordered more than a half billion testing kits from China.

But the chief of epidemiology at the Indian Council of Medical Research, Dr R R Gangakhedkar, said he had asked health authorities to temporarily stop the tests for antibodies because of conflicting results.

Coronavirus News India LIVE Updates

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"This is a first-generation test developed in just three-and-a-half months and needs refinement, the variations cannot be ignored," he said.

Federal health experts have been sent to help authorities in states to validate the equipment.

"We have advised the states not to use them for the next two days until we come out with an advisory," he said.

The antibody tests do not always pick up early-stage infections but show whether a person had the virus in the past, even if the person had no symptoms of COVID-19, the disease caused by the novel coronavirus.

In comparison, the swab test, known as the RT-PCR-technology swab test, determines whether a person has the virus at that moment by looking for it in nose or throat secretions.

Catch our entire coverage on the Facebook-Jio deal here

The health minister of the western state of Rajasthan said the two tests were in some cases producing conflicting results, raising doubts reliability.

"The kits were used for testing of patients who have already tested positive for coronavirus," the state minister, Raghu Sharma said.

"But the rapid test kits found them negative, which raised questions about the credibility of these kits."

Both tests are seen as critical in the coronavirus fight, but antibody tests are a relatively cheap, fast means to sort populations into risk groups and measure the spread of the virus.

India has detected 19,983 cases of the coronavirus, after an increase of nearly 1,000 cases in one day, according to the government data.

There have been 640 deaths, still a small number compared with tolls in many other countries but officials say the infections could rise once a nearly six-week lockdown is lifted on May 3.

Big cities of Delhi and Mumbai and their adjoining areas have taken the brunt of the infection, leaving the countryside less affected.

Here are official government figures on the spread of the coronavirus in South Asia:

      • India has reported 19,983 cases, including 640 deaths
      • Pakistan has reported 9,747 cases, including 209 deaths
      • Afghanistan has reported 1,092 cases, including 36 deaths
      • Sri Lanka has reported 310 cases, including seven deaths
      • Bangladesh has reported 2,948 cases, including 101 deaths
      • Maldives has reported 34 cases and no deaths
      • Nepal has reported 42 cases and no deaths
      • Bhutan has reported six cases and no deaths


Follow our full coverage of the coronavirus pandemic here.
Reuters
first published: Apr 22, 2020 02:55 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347